As our GSEA shows that transcriptional level of EMT in vimentin-expressing cancer cells was opposed by IFNα response, vimentin-expressing cancer cells could evade cytotoxic IFNα response and exert higher fitness in the patient, particularly in an inflammatory tumor microenvironment. The gene discussed is IFNA1; the disease is cancer.